Employment Among Users of a Medically Supervised Safer Injection Facility

REFERENCES

• Aceijas C, Stimson G V, Hickman M, Rhodes T, United Nations Reference Group on HIV/AIDS Prevention and Care among IDU in Developing and Transitional Countries. Global overview of injecting drug use and HIV infection among injecting drug users. AIDS Nov 19, 2004; 18(17)2295–303
   PubMed Web of Science ®Google Scholar
• Kimber J, Dolan K, van Beek I, Hedrich D, Zurhold H. Drug consumption facilities: An update since 2000. Drug and Alcohol Review 2003; 22(2)227–33
   PubMed Web of Science ®Google Scholar
• Wright N M, Tompkins C N. Supervised injecting centres. BMJ 2004; 328(7431)100–2
   PubMed Web of Science ®Google Scholar
• Wood E, Kerr T, Lloyd-Smith E, Buchner C, Marsh D C, Montaner J S, Tyndall M W. Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users. Harm Reduct J 2004; 1(1)9
   PubMedGoogle Scholar
• Wood E, Tyndall M W, Montaner J S, Kerr T. Summary of findings from the evaluation of a pilot medically supervised safer injecting facility. CMAJ 2006; 175(11)1399–404
   PubMed Web of Science ®Google Scholar
• Mangham C. A critique of Canada's INSITE injection site and its parent philosophy: Implications and recommendations for policy planning. J Global Drug Pol and Pract August 7, 2007; 1(2), Available from: http://www.globaldrugpolicy.org/1/2/2.php Last accessed 7 August 2007
   Google Scholar
• CBC News. Police group takes aim at Vancouver safe injection site, CBC News. Sept 1 2006
   Google Scholar
• Ritter A, Cameron J. A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs. Drug and Alcohol Review. 2006; 25(6)611–624
   PubMed Web of Science ®Google Scholar
• Platt J J. Vocational rehabilitation of drug abusers. Psychol Bull 1995; 117(3)416–33
   PubMed Web of Science ®Google Scholar
• Vaillant G E. What can long-term follow-up teach us about relapse and prevention of relapse in addiction?. Br J Addict 1988; 83(10)1147–57
   PubMedGoogle Scholar
• Hills J, Le Grand J, Piachaud D. Understanding social exclusion. Oxford University Press, Oxford 2002
   Google Scholar
• Magura S, Staines G L, Blankertz L, Madison E M. The effectiveness of vocational services for substance users in treatment. Subst Use Misuse 2004; 39(13–14)2165–213
   PubMed Web of Science ®Google Scholar
• March J C, Oviedo-Joekes E, Romero M. Drugs and social exclusion in ten European cities. Eur Addict Res 2006; 12(1)33–41
   PubMed Web of Science ®Google Scholar
• Hser Y I, Hoffman V, Grella C E, Anglin M D. A 33-year follow-up of narcotics addicts. Arch Gen Psych 2001; 58(5)503–8
   PubMed Web of Science ®Google Scholar
• Lundgren L M, Schilling R F, Ferguson F, Davis K, Amodeo M. Examining drug treatment program entry of injection drug users: Human capital and institutional disaffiliation. Eval Program Planning 2003; 26(2)123–32
   PubMedGoogle Scholar
• Wood E, Tyndall M W, Spittal P M, Li K, Kerr T, Hogg R S, Montaner J S, O'Shaughnessy M V, Schechter M T. Unsafe injection practices in a cohort of injection drug users in Vancouver: Could safer injecting rooms help?. CMAJ 2001; 165(4)405–10
   PubMed Web of Science ®Google Scholar
• Stoltz J A, Wood E, Small W, Li K, Tyndall M, Montaner J, Kerr T. Changes in injecting practices associated with the use of a medically supervised safer injection facility. J Public Health 2007; 29(1)35–9
   Web of Science ®Google Scholar
• Shah N G, Celentano D D, Vlahov D, Stambolis V, Johnson L, Nelson K E, et al. Correlates of enrollment in methadone maintenance treatment programs differ by HIV-serostatus. AIDS 2000; 14(13)2035–43
   PubMed Web of Science ®Google Scholar
• Wood E, Tyndall M W, Zhang R, Montaner J S, Kerr T. Rate of detoxification service use and its impact among a cohort of supervised injecting facility users. Addiction 2007; 102(6)916–9
   PubMed Web of Science ®Google Scholar
• Kerr T, Tyndall M, Li K, Montaner J, Wood E. Safer injection facility use and syringe sharing in injection drug users. Lancet 2005; 366(9482)316–8
   PubMed Web of Science ®Google Scholar
• Reif S, Horgan C M, Ritter G A, Tompkins C P. The impact of employment counseling on substance user treatment participation and outcomes. Subs Use Misuse 2004; 39(13)2391
   PubMedGoogle Scholar
• Fairbairn N, Wood E, Small W, Stoltz J A, Li K, Kerr T. Risk profile of individuals who provide assistance with illicit drug injections. Drug Alcohol Depend 2006; 82(1)41–6
   PubMedGoogle Scholar
• Miller C L, Kerr T, Frankish J C, Spittal P M, Li K, Schechter M T, et al. Binge drug use independently predicts HIV seroconversion among injection drug users: Implications for public health strategies. Subst Use Misuse 2006; 41(2)199–210
   PubMed Web of Science ®Google Scholar
• Kerr T, Fairbairn N, Tyndall M, Marsh D, Li K, Montaner J, Wood E. Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug Alcohol Depend. 2007; 87(1)39–45
   PubMed Web of Science ®Google Scholar